LRRC15/LIB, His, Canine
LRRC15/LIB, His, Canine

The purity of LRRC15/LIB, His, Canine is greater than 95% as determined by SEC-HPLC.

LRRC15/LIB, His, Canine

LRRC15/LIB, His, Canine on Bis-Tris PAGE under reduced condition. The purity is greater than 95%.

LRRC15/LIB, His, Canine

The chimeric protein binds in vitro and in vivo to a specific element upstream of LRRC15, leading to dramatic transcriptional activation. LRRC15 encodes a leucine-rich transmembrane protein, present at the leading edge of migrating cells, the expression of which in normal tissues is restricted to the invasive cytotrophoblast layer of the placenta; small interfering (siRNA)-mediated suppression of LRRC15 expression in breast cancer cells leads to abrogation of invasiveness in vitro.
Z04707
¥72,752.00

Ask us a question
Product Introduction
Species Canine
Protein Construction
LRRC15/LIB (Tyr47-Gly565)
Accession # XP_005639692.2		 His
N-term C-term
Purity > 95% as determined by Bis­Tris PAGE 
Endotoxin Level Less than 1EU per μg by the LAL method.
Expression System HEK293
Theoretical Molecular Weight 59.32 kDa
Apparent Molecular Weight Due to glycosylation, the protein migrates to 70-80 kDa based on Bis-Tris PAGE result.
Formulation Lyophilized from 0.22μm filtered solution in PBS (pH 7.4).
Reconstitution Centrifuge the tube before opening. Reconstituting to a concentration more than 100 μg/ml is recommended. Dissolve the lyophilized protein in distilled water.
Storage & Stability Upon receiving, the product remains stable for 6 months at -20℃ or below. Upon reconstitution, the product should be stable for 3 months at -80℃. Avoid repeated freeze-thaw cycles.

Examples
  • LRRC15/LIB, His, Canine
    • LRRC15/LIB, His, Canine

    The purity of LRRC15/LIB, His, Canine is greater than 95% as determined by SEC-HPLC.

  • LRRC15/LIB, His, Canine
    • LRRC15/LIB, His, Canine

    LRRC15/LIB, His, Canine on Bis-Tris PAGE under reduced condition. The purity is greater than 95%.


Background
Target Background The chimeric protein binds in vitro and in vivo to a specific element upstream of LRRC15, leading to dramatic transcriptional activation. LRRC15 encodes a leucine-rich transmembrane protein, present at the leading edge of migrating cells, the expression of which in normal tissues is restricted to the invasive cytotrophoblast layer of the placenta; small interfering (siRNA)-mediated suppression of LRRC15 expression in breast cancer cells leads to abrogation of invasiveness in vitro.
Synonyms LIB; LRRC15

For research use only. Not intended for human or animal clinical trials, therapeutic or diagnostic use.